Skip to content

Study to evaluate osteoarthritis and nociceptive pain by measuring microRNA in blood samples

investigation of miRNA biomarkers in Osteoarthritis and nociceptive pain - KMS-pain biomarker project

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000052943
Enrollment
180
Registered
2024-01-01
Start date
2024-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

None listed

Sponsors

Kawasaki Medical School
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: OA group Indication criteria 1) Patients scheduled for THA due to osteoarthritis of the hip joint. 2) Patients who understand the purpose and content of this study and have given written consent to participate in the study of their own free will. Fracture group Indication criteria 1) Patients undergoing surgery for artificial bone replacement due to femur fracture 2) Patients who understand the purpose and content of this study and have given written consent to participate in the study of their own free will. Normal group Indication criteria (1) Patients without pain that has persisted for more than 3 months 2) Patients between 20 and 80 years of age. (3) Persons who understand the purpose and content of this study and who have given written consent to participate in the study of their own free will.

Exclusion criteria

Exclusion criteria: OA group Exclusion criteria 1) Patients with severe pain in a location other than the hip joint (bilateral hip osteoarthritis is not excluded) 2) Patients with severe cognitive dysfunction (delirium, dementia, mental retardation, or other mental decline) at the time of preintervention evaluation. 3) Patients who have difficulty in communicating, reading, and writing in Japanese 4) Other subjects deemed inappropriate for this study by the principal investigator Fracture group Exclusion criteria 1) Patients with preoperative severe osteoarthritis of the hip joint 2) Patients with severe cognitive dysfunction (delirium, dementia, mental retardation, or other mental decline) at the time of preintervention evaluation 3) Patients who have difficulty in communicating, reading, and writing in Japanese. 4) Other subjects deemed inappropriate for this study by the principal investigator Normal group Exclusion Criteria 1) Patients with illnesses requiring immediate medical treatment 2) Persons with a history of alcohol or drug abuse or those who admit it at this time 3) Persons with a history of manic or psychotic states, or those who admit it at present 4) Persons who have or currently admit to having significant feelings of hopelessness 5) Those with strong cognitive impairment. 6) Those who have difficulty in communicating, reading, and writing in Japanese. 7) Others who the principal investigator deems inappropriate to participate in the research.

Design outcomes

Primary

MeasureTime frame
Expression levels of miRNAs in OA patients and healthy subjects

Countries

Japan

Contacts

Public ContactHiroyuki Nishie

Kawasaki Medical School Department of Advanced Oncoloby

nishiehiroyuki@med.kawasaki-m.ac.jp0564621111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026